Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
40.4M
-
Number of holders
-
114
-
Total 13F shares, excl. options
-
36.2M
-
Shares change
-
+268K
-
Total reported value, excl. options
-
$243M
-
Value change
-
+$1.66M
-
Put/Call ratio
-
83.02
-
Number of buys
-
55
-
Number of sells
-
-48
-
Price
-
$6.73
Significant Holders of Pulmonx Corp - COMMON STOCK (LUNG) as of Q1 2025
137 filings reported holding LUNG - Pulmonx Corp - COMMON STOCK as of Q1 2025.
Pulmonx Corp - COMMON STOCK (LUNG) has 114 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 36.2M shares
of 40.4M outstanding shares and own 89.56% of the company stock.
Largest 10 shareholders include FMR LLC (5.42M shares), PRIMECAP MANAGEMENT CO/CA/ (5.41M shares), MORGAN STANLEY (3.49M shares), BlackRock, Inc. (2.79M shares), VANGUARD GROUP INC (2.28M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (1.89M shares), BNP PARIBAS ASSET MANAGEMENT Holding S.A. (1.25M shares), DEUTSCHE BANK AG\ (1.15M shares), SILVERCREST ASSET MANAGEMENT GROUP LLC (931K shares), and GEODE CAPITAL MANAGEMENT, LLC (928K shares).
This table shows the top 114 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.